Mary Mihalovic

Dolutegravir a Promising Treatment Option for HIV
03/18/2014
Dolutegravir, used with abacavir and lamivudine, showed more efficacy and a better safety profile in the treatment of HIV-1 infection compared with EFV-TDF-FTC.
Dolutegravir, used with abacavir and lamivudine, showed more efficacy and a better safety profile in the treatment of HIV-1 infection compared with EFV-TDF-FTC.
Dolutegravir, used with abacavir...
03/18/2014
First Report Managed Care
Conference Insider
Translating Trial Results Into Real-World Practice in IMIDs
09/24/2015
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical...
09/24/2015
First Report Managed Care
Inhaled Corticosteroids Overprescribed for COPD
11/27/2012
Cincinnati—A large percentage of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) are being prescribed maintenance therapy with inhaled corticosteroids (ICS), a practice that is not consistent with the Global...
Cincinnati—A large percentage of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) are being prescribed maintenance therapy with inhaled corticosteroids (ICS), a practice that is not consistent with the Global...
Cincinnati—A large percentage of...
11/27/2012
First Report Managed Care
News Connection
Platelet Inhibition to Bridge Patients for CABG
03/16/2012
The use of cangrelor, an intravenous antagonist of the P2Y12 receptor, to bridge patients after they discontinue antiplatelet therapy in preparation for coronary artery bypass graft (CABG) surgery, was shown to effectively provide platelet...
The use of cangrelor, an intravenous antagonist of the P2Y12 receptor, to bridge patients after they discontinue antiplatelet therapy in preparation for coronary artery bypass graft (CABG) surgery, was shown to effectively provide platelet...
The use of cangrelor, an...
03/16/2012
First Report Managed Care
Risks of In-Hospital Worsening Heart Failure
12/15/2014
The results of a recent study found that in-hospital worsening heart failure was common and associated with higher rates of mortality, all-cause readmission, and Medicare payments.
The results of a recent study found that in-hospital worsening heart failure was common and associated with higher rates of mortality, all-cause readmission, and Medicare payments.
The results of a recent study...
12/15/2014
First Report Managed Care
Routine Use of Aspirin for Primary Prevention of Cardiovascular Events
02/21/2012
The use of aspirin for primary prevention of cardiovascular events was not shown to be beneficial for preventing fatal myocardial infarction (MI), stroke, or death related to cardiovascular disease (CVD) or cancer, according to results of a...
The use of aspirin for primary prevention of cardiovascular events was not shown to be beneficial for preventing fatal myocardial infarction (MI), stroke, or death related to cardiovascular disease (CVD) or cancer, according to results of a...
The use of aspirin for primary...
02/21/2012
First Report Managed Care
CSS to Increase CMS Acute MI Core Measure Compliance
03/18/2014
The computerized clinical surveillance system (CSS), known as TheraDoc, is used to increase Centers for Medicare & Medicaid Services (CMS) core measure compliance among patients with acute myocardial infarction (MI). CSS was recently studied...
The computerized clinical surveillance system (CSS), known as TheraDoc, is used to increase Centers for Medicare & Medicaid Services (CMS) core measure compliance among patients with acute myocardial infarction (MI). CSS was recently studied...
The computerized clinical...
03/18/2014
First Report Managed Care
Conference Insider
Patients With Celiac Disease Incur Significantly Higher Direct Costs
07/30/2015
Retrospective claims analysis points to the likely reasons, and compares cost burden to that of ulcerative colitis.
Retrospective claims analysis points to the likely reasons, and compares cost burden to that of ulcerative colitis.
Retrospective claims analysis...
07/30/2015
First Report Managed Care
Contraceptive Utilization Expected to Rise as Costs to Consumers Decrease
11/27/2012
Cincinnati—The implementation of the Patient Protection and Affordable Care Act (ACA), which will provide contraception to consumers as a preventive service without cost sharing, is expected to result in an increase of contraception costs to...
Cincinnati—The implementation of the Patient Protection and Affordable Care Act (ACA), which will provide contraception to consumers as a preventive service without cost sharing, is expected to result in an increase of contraception costs to...
Cincinnati—The implementation of...
11/27/2012
First Report Managed Care
News Connection
Multifaceted Intervention Leads to Improved Cardioprotective Medication Adherence
01/20/2014
The use of a multifaceted intervention led to improved adherence to cardioprotective medications after hospital discharge for acute coronary syndrome (ACS) by approximately 15%, according to results of a recent study [JAMA Intern Med....
The use of a multifaceted intervention led to improved adherence to cardioprotective medications after hospital discharge for acute coronary syndrome (ACS) by approximately 15%, according to results of a recent study [JAMA Intern Med....
The use of a multifaceted...
01/20/2014
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use